CN105853795A - Bag-packed preparation with cerebrovascular disease rehabilitation effect - Google Patents

Bag-packed preparation with cerebrovascular disease rehabilitation effect Download PDF

Info

Publication number
CN105853795A
CN105853795A CN201610330506.8A CN201610330506A CN105853795A CN 105853795 A CN105853795 A CN 105853795A CN 201610330506 A CN201610330506 A CN 201610330506A CN 105853795 A CN105853795 A CN 105853795A
Authority
CN
China
Prior art keywords
parts
cerebrovascular disease
nostoc
ginkgo
folium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610330506.8A
Other languages
Chinese (zh)
Inventor
杨纯生
齐国豪
杨万秋
王静
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xinxiang Medical University
Original Assignee
Xinxiang Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xinxiang Medical University filed Critical Xinxiang Medical University
Priority to CN201610330506.8A priority Critical patent/CN105853795A/en
Publication of CN105853795A publication Critical patent/CN105853795A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/52—Juglandaceae (Walnut family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a bag-packed preparation with a cerebrovascular disease rehabilitation effect. The bag-packed preparation is prepared from the following raw materials in parts by weight: 2-3 parts of folium ginkgo, 1-2 parts of radix notoginseng, 2-3 parts of nostoc commune freeze-dried powder, 3-5 parts of cyclocarya paliurus leaves, 3-5 parts of apocynum venetum, 1-3 parts of corn stigmas, 2-3 parts of olive leaves, 5-7 parts of natto powder, 3-5 parts of crataegus ginkgo, 7-10 parts of radix paeoniae rubra, 3-5 parts of orange peels, 1-3 parts of gynura divaricata and 3-5 parts of mistletoe. Through reasonable selection and proportion of the components, the bag-packed preparation disclosed by the invention has the functions of resisting thrombus formation, improving microcirculation, strengthening heart, dilating coronary artery, increasing coronary blood flow, resisting myocardial ischemia, regulating blood lipid, reducing blood pressure, enhancing immunity, reducing lipid, strengthening heart, resisting atherosclerosis and the like and is obvious in treatment effect, mild in medicine property, free from toxic and side effects, simple in preparation process and convenient to eat and carry simultaneously.

Description

Cerebrovascular disease has the bagged tea of recovery function
Technical field
The present invention relates to a kind of health care bagged tea, be specifically related to a kind of cerebrovascular disease and there is recovery function Bagged tea.
Background technology
Cardiopathia cerebrovascular disease is exactly the general designation of cardiovascular and cerebrovascular disease, has become as the harm whole mankind One of healthy serious disease.Cardiovascular and cerebrovascular disease have " sickness rate is high, disability rate high, mortality rate is high, Relapse rate is high, and complication is many " i.e. the feature of " four is high by more than ".China's Patients with Cardiovascular/Cerebrovascular Diseases is at present More than 2.7 hundred million people, die from nearly 3,000,000 people of cardiovascular and cerebrovascular disease every year, account for China's total Death causes every year 51%.Prevention and the treatment of cardiovascular disease have become the realistic problem that the whole world is urgently to be resolved hurrily.
At present, method or the medicine for the treatment of cardiovascular and cerebrovascular disease are varied, and surgical operation, such as bridging hands Art, intervention are performed the operation, are changed vascular surgery etc.；Traditional western medicine, as aspirin, beta-blocker, he Spit of fland class medicine etc.；Health product, such as fish oil class, propolis, Oleum Bulbus Allii, Semen Ginkgo etc.；Common Chinese medicine, such as worm Class medicine, Chinese medicine and western medicine compound formulation, Chinese medicine preparation etc..Above Therapeutic Method be cardio-cerebral vascular disease patient frequently with Treatment option, but surgical operation has, and risk is big, the shortcoming of somewhat expensive；Western medicine only has long-term taking Could benefit, the most easily rebound, and side effect is big, damage ratio renovascular to liver is more serious, even There is serious untoward reaction；Health product Main Function is the effect of lubrication expansion blood vessel, only serves auxiliary Effect, it is impossible to from basic treatment.
Summary of the invention
For solving the problems referred to above, the invention provides a kind of cerebrovascular disease and there is the bagged tea of recovery function, Have that preparation technology is simple, evident in efficacy, mild in medicine property and, have no side effect, instant, easy to carry Advantage.
For achieving the above object, the technical scheme that the present invention takes is:
Cerebrovascular disease has the bagged tea of recovery function, the raw material of following weight portion be prepared from:
Folium Ginkgo 2-3 part, Radix Notoginseng 1-2 part, Nostoc lyophilized powder 2-3 part, leaf of Cyclocarya paliurus Iljinskaja 3-5 part, Herba Apocyni veneti 3-5 part, Stigma Maydis 1-3 part, Folium olive 2-3 part, natto powder 5-7 part, May Semen Ginkgo 3-5 Part, Radix Paeoniae Rubra 7-10 part, Pericarpium Citri tangerinae 3-5 part, gold Pterocladia tenuis Okam. 1-3 part, Herba Visci 3-5 part.
Preferably, the raw material of following weight portion it is prepared from:
Folium Ginkgo 2 parts, Radix Notoginseng 1 part, Nostoc lyophilized powder 2 parts, leaf of Cyclocarya paliurus Iljinskaja 3 parts, Herba Apocyni veneti 3 Part, Stigma Maydis 1 part, 2 parts of Folium olive, natto powder 5 parts, May Semen Ginkgo 3 parts, Radix Paeoniae Rubra 7 parts, Pericarpium Citri tangerinae 3 parts, gold Pterocladia tenuis Okam. 1 part, Herba Visci 3 parts.
Preferably, the raw material of following weight portion it is prepared from:
Folium Ginkgo 3 parts, Radix Notoginseng 2 parts, Nostoc lyophilized powder 3 parts, leaf of Cyclocarya paliurus Iljinskaja 5 parts, Herba Apocyni veneti 5 Part, Stigma Maydis 3 parts, 3 parts of Folium olive, natto powder 7 parts, May Semen Ginkgo 5 parts, Radix Paeoniae Rubra 10 parts, Pericarpium Citri tangerinae 5 parts, gold Pterocladia tenuis Okam. 3 parts, Herba Visci 5 parts.
Preferably, Folium Ginkgo 2.5 parts, Radix Notoginseng 1.5 parts, Nostoc lyophilized powder 2.5 parts, leaf of Cyclocarya paliurus Iljinskaja 4 parts, Herba Apocyni veneti 4 parts, Stigma Maydis 2 parts, 2.5 parts of Folium olive, natto powder 6 parts, May Semen Ginkgo 4 Part, Radix Paeoniae Rubra 8.5 parts, Pericarpium Citri tangerinae 4 parts, gold Pterocladia tenuis Okam. 2 parts, Herba Visci 4 parts.
Wherein, described Nostoc lyophilized powder is prepared by following steps:
Taking Nostoc, clean and be placed in steam-explosion jar, being first passed through nitrogen to steam explosion pressure inside the tank is 0.6-1.7MPa, explosion treatment 6-26min；Being passed through the most rapidly steam to steam explosion pressure inside the tank is 1.7-2.3MPa, after Steam explosion treatment 0.8-2.8min, connects according to the ratio of inoculum concentration 1.5-1.7% Plant microbe leaven, keep temperature 25-35 DEG C, after fermenting 48-54 hour, high-temperature inactivation, low-temperature frozen Dry.
Wherein, described microbe leaven is pressed matter by lactobacillus, Bacillus licheniformis, Corynebacterium glutamicum Amount is than 3:2:1 mixing gained.
The present invention has following effective:
Rationally selecting and proportioning by composition, have in antithrombus formation, improve microcirculation, heart tonifying coronary dilating, Increase coronary flow, resist myocardial ischemia, Adjust-blood lipid, blood pressure lowering, enhancing immunity, fat-lowering cardiotonic, anti- The functions such as atherosclerosis, evident in efficacy, mild in medicine property and, have no side effect, and preparation technology is simple, Instant, easy to carry simultaneously.
Detailed description of the invention
In order to make objects and advantages of the present invention clearer, below in conjunction with embodiment, the present invention is carried out Further describe.Should be appreciated that specific embodiment described herein only in order to explain the present invention, It is not intended to limit the present invention.
In following example, the Nostoc lyophilized powder used is prepared by following steps: takes Nostoc, washes Only being placed in steam-explosion jar, being first passed through nitrogen to steam explosion pressure inside the tank is 0.6-1.7MPa, explosion treatment 6-26min；Being passed through the most rapidly steam to steam explosion pressure inside the tank is 1.7-2.3MPa, Steam explosion treatment After 0.8-2.8min, according to the ratio microbe inoculation leaven of inoculum concentration 1.5-1.7%, keep temperature 25-35 DEG C, after fermenting 48-54 hour, high-temperature inactivation, low-temperature freeze drying.Wherein, described fermentable Agent is mixed gained by lactobacillus, Bacillus licheniformis, Corynebacterium glutamicum in mass ratio 3: 2: 1.
Embodiment 1
Folium Ginkgo 2 parts, Radix Notoginseng 1 part, Nostoc lyophilized powder 2 parts, leaf of Cyclocarya paliurus Iljinskaja 3 parts, Herba Apocyni veneti 3 Part, Stigma Maydis 1 part, 2 parts of Folium olive, natto powder 5 parts, May Semen Ginkgo 3 parts, Radix Paeoniae Rubra 7 parts, Pericarpium Citri tangerinae 3 parts, gold Pterocladia tenuis Okam. 1 part, Herba Visci 3 parts.
Embodiment 2
Folium Ginkgo 3 parts, Radix Notoginseng 2 parts, Nostoc lyophilized powder 3 parts, leaf of Cyclocarya paliurus Iljinskaja 5 parts, Herba Apocyni veneti 5 Part, Stigma Maydis 3 parts, 3 parts of Folium olive, natto powder 7 parts, May Semen Ginkgo 5 parts, Radix Paeoniae Rubra 10 parts, Pericarpium Citri tangerinae 5 parts, gold Pterocladia tenuis Okam. 3 parts, Herba Visci 5 parts.
Embodiment 3
Folium Ginkgo 2.5 parts, Radix Notoginseng 1.5 parts, Nostoc lyophilized powder 2.5 parts, leaf of Cyclocarya paliurus Iljinskaja 4 parts, sieve Cloth fiber crops 4 parts, Stigma Maydis 2 parts, 2.5 parts of Folium olive, natto powder 6 parts, May Semen Ginkgo 4 parts, red Chinese herbaceous peony 8.5 parts, Pericarpium Citri tangerinae 4 parts, gold Pterocladia tenuis Okam. 2 parts, Herba Visci 4 parts.
Originally it is embodied as 200 healthy populations are tracked experiment, wherein male 80 example, women 120 example, Mean age is 45 years old, maximum 70 years old, minimum 40 years old.Often drink the bagged tea of the present invention, after 5 years, 200 people suffer from people only 6 example of cardiovascular and cerebrovascular disease, well below cardiovascular and cerebrovascular disease ill generally Rate, it was demonstrated that the bagged tea often drinking the present invention has good preventive effect to cardiovascular and cerebrovascular disease.
200 example Patients with Cardiovascular/Cerebrovascular Diseases are tracked treatment, wherein male 80 example, women 120 example, put down All ages are 55 years old, maximum 79 years old, minimum 42 years old.Often drink the bagged tea of the present invention, wherein have 110 The example state of an illness has taken a turn for the better, and 52 examples have obvious rehabilitation efficacy, 38 example DeGrains, it was demonstrated that often drink this The bagged tea of invention has good rehabilitative action to Patients with Cardiovascular/Cerebrovascular Diseases.
The above is only the preferred embodiment of the present invention, it is noted that common for the art For technical staff, under the premise without departing from the principles of the invention, it is also possible to make some improvements and modifications, These improvements and modifications also should be regarded as protection scope of the present invention.

Claims (6)

1. cerebrovascular disease has the bagged tea of recovery function, it is characterised in that former by following weight portion Material is prepared from:
Folium Ginkgo 2-3 part, Radix Notoginseng 1-2 part, Nostoc lyophilized powder 2-3 part, leaf of Cyclocarya paliurus Iljinskaja 3-5 part, Herba Apocyni veneti 3-5 part, Stigma Maydis 1-3 part, Folium olive 2-3 part, natto powder 5-7 part, May Semen Ginkgo 3-5 Part, Radix Paeoniae Rubra 7-10 part, Pericarpium Citri tangerinae 3-5 part, gold Pterocladia tenuis Okam. 1-3 part, Herba Visci 3-5 part.
2. cerebrovascular disease as claimed in claim 1 has the bagged tea of recovery function, it is characterised in that It is prepared from by the raw material of following weight portion:
Folium Ginkgo 2 parts, Radix Notoginseng 1 part, Nostoc lyophilized powder 2 parts, leaf of Cyclocarya paliurus Iljinskaja 3 parts, Herba Apocyni veneti 3 Part, Stigma Maydis 1 part, 2 parts of Folium olive, natto powder 5 parts, May Semen Ginkgo 3 parts, Radix Paeoniae Rubra 7 parts, Pericarpium Citri tangerinae 3 parts, gold Pterocladia tenuis Okam. 1 part, Herba Visci 3 parts.
3. cerebrovascular disease as claimed in claim 1 has the bagged tea of recovery function, it is characterised in that It is prepared from by the raw material of following weight portion:
Folium Ginkgo 3 parts, Radix Notoginseng 2 parts, Nostoc lyophilized powder 3 parts, leaf of Cyclocarya paliurus Iljinskaja 5 parts, Herba Apocyni veneti 5 Part, Stigma Maydis 3 parts, 3 parts of Folium olive, natto powder 7 parts, May Semen Ginkgo 5 parts, Radix Paeoniae Rubra 10 parts, Pericarpium Citri tangerinae 5 parts, gold Pterocladia tenuis Okam. 3 parts, Herba Visci 5 parts.
4. cerebrovascular disease as claimed in claim 1 has the bagged tea of recovery function, it is characterised in that Folium Ginkgo 2.5 parts, Radix Notoginseng 1.5 parts, Nostoc lyophilized powder 2.5 parts, leaf of Cyclocarya paliurus Iljinskaja 4 parts, Herba Apocyni veneti 4 parts, Stigma Maydis 2 parts, 2.5 parts of Folium olive, natto powder 6 parts, May Semen Ginkgo 4 parts, Radix Paeoniae Rubra 8.5 Part, Pericarpium Citri tangerinae 4 parts, gold Pterocladia tenuis Okam. 2 parts, Herba Visci 4 parts.
5. cerebrovascular disease as claimed in claim 1 has the bagged tea of recovery function, it is characterised in that Described Nostoc lyophilized powder is prepared by following steps:
Taking Nostoc, clean and be placed in steam-explosion jar, being first passed through nitrogen to steam explosion pressure inside the tank is 0.6-1.7MPa, explosion treatment 6-26min；Being passed through the most rapidly steam to steam explosion pressure inside the tank is 1.7-2.3MPa, after Steam explosion treatment 0.8-2.8min, connects according to the ratio of inoculum concentration 1.5-1.7% Plant microbe leaven, keep temperature 25-35 DEG C, after fermenting 48-54 hour, high-temperature inactivation, low-temperature frozen Dry.
6. cerebrovascular disease as claimed in claim 5 has the bagged tea of recovery function, it is characterised in that Described microbe leaven is by lactobacillus, Bacillus licheniformis, Corynebacterium glutamicum in mass ratio 3: 2: 1 Mixing gained.
CN201610330506.8A 2016-05-13 2016-05-13 Bag-packed preparation with cerebrovascular disease rehabilitation effect Pending CN105853795A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610330506.8A CN105853795A (en) 2016-05-13 2016-05-13 Bag-packed preparation with cerebrovascular disease rehabilitation effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610330506.8A CN105853795A (en) 2016-05-13 2016-05-13 Bag-packed preparation with cerebrovascular disease rehabilitation effect

Publications (1)

Publication Number Publication Date
CN105853795A true CN105853795A (en) 2016-08-17

Family

ID=56634501

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610330506.8A Pending CN105853795A (en) 2016-05-13 2016-05-13 Bag-packed preparation with cerebrovascular disease rehabilitation effect

Country Status (1)

Country Link
CN (1) CN105853795A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106237117A (en) * 2016-10-19 2016-12-21 吉林大学珠海学院 A kind of Chinese medicine composition of blood circulation promoting and blood stasis dispelling
CN110419742A (en) * 2018-08-07 2019-11-08 湖南炎帝生物工程有限公司 Nostoc composition and its application in adjusting blood lipid, prevention and/or treatment atherosclerosis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103609787A (en) * 2013-10-31 2014-03-05 安徽博格生物科技有限公司 Tea bag helping to recuperate from cardio cerebrovascular disease
CN103609765A (en) * 2013-10-31 2014-03-05 安徽博格生物科技有限公司 Bagged preparation for preventing and treating hypertension disease
CN103652159A (en) * 2013-10-31 2014-03-26 安徽博格生物科技有限公司 Tea bag for preventing and treating hyperlipidemia diseases
CN105533188A (en) * 2016-01-25 2016-05-04 内蒙古民族大学 Economic feed additive for promoting growth of sheep

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103609787A (en) * 2013-10-31 2014-03-05 安徽博格生物科技有限公司 Tea bag helping to recuperate from cardio cerebrovascular disease
CN103609765A (en) * 2013-10-31 2014-03-05 安徽博格生物科技有限公司 Bagged preparation for preventing and treating hypertension disease
CN103652159A (en) * 2013-10-31 2014-03-26 安徽博格生物科技有限公司 Tea bag for preventing and treating hyperlipidemia diseases
CN105533188A (en) * 2016-01-25 2016-05-04 内蒙古民族大学 Economic feed additive for promoting growth of sheep

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106237117A (en) * 2016-10-19 2016-12-21 吉林大学珠海学院 A kind of Chinese medicine composition of blood circulation promoting and blood stasis dispelling
CN110419742A (en) * 2018-08-07 2019-11-08 湖南炎帝生物工程有限公司 Nostoc composition and its application in adjusting blood lipid, prevention and/or treatment atherosclerosis
CN110419740A (en) * 2018-08-07 2019-11-08 湖南炎帝生物工程有限公司 Nostoc composition and its application in improvement cognitive ability

Similar Documents

Publication Publication Date Title
CN102550757A (en) Health-care tea
CN102488883B (en) Traditional Chinese medicine composition for treating chronic colitis and preparation method thereof
CN101124932A (en) Decoction preparation for treating viral hepatitis associated with fatty liver diseases
CN105853795A (en) Bag-packed preparation with cerebrovascular disease rehabilitation effect
CN107494817A (en) A kind of hypoglycemic tea
CN104352921B (en) Chinese medicine composition with increase bone density effect and its preparation method and application
CN103893066A (en) Camellia oil for washing and caring hair
CN104225104A (en) Chinese herbal medicine blood pressure lowering tea and preparation method thereof
CN103815332A (en) Chuanminshen violaceum yin-nourishing blood-replenishing hot-pot condiment and preparation method thereof
CN105995281A (en) Drinking containing ginseng
CN109170473A (en) A kind of solid beverage formula and its processing method with blood nourishing function
CN104721092A (en) Bath lotion containing water extract of ginkgo leaves and preparation method thereof
CN109260403A (en) A kind of Chinese medicine composition for treating cancer of pancreas
CN107823291A (en) Chinese medicine composition of hypertension and preparation method thereof caused by a kind of conditioning diabetes
CN107890549A (en) A kind of Chinese medicine composition and preparation method for treating cardiovascular and cerebrovascular disease
CN102028895A (en) Medicinal composition with antioxidant activity and blood vessel and blood cleaning antioxidant and/or protective agent
CN107137682A (en) A kind of Chinese medicine composition for treating apoplexy and application
CN105641429A (en) Rhaphidop hora hongkongensis shott blood circulation activation and blood stasis removing bath powder and production method thereof
CN106334088A (en) Effective composition for kidney-reinforcing functional food and preparation method thereof
CN106138448A (en) Chinese medicine preparation for hair washing and preparation method thereof
CN1994140A (en) Paste with fleece-flower root and sesame for reducing fat, protecting liver and preventing against osteoprosis
CN104938726A (en) Substitutional tea for reducing blood fat
CN105012905A (en) Liquor capable of tonifying deficiency, nourishing blood and dredging collaterals
CN104371890A (en) Anti-fatigue and senescence-delaying health wine
CN103431109A (en) Heart-nourishing food health-preserving tea granule

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160817

RJ01 Rejection of invention patent application after publication